Mechanisms for enhanced endothelium-derived hyperpolarizing factor-mediated responses in microvessels in mice

Circulation Journal

Volumn 76, Issue 7, 2012, Pages 1768-1779

  Ohashi, Junko ^a   Sawada, Ayuko ^a   Nakajima, Sota ^a   Noda, Kazuki ^a   Takaki, Aya ^a   Shimokawa, Hiroaki ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Endothelial nitric oxide synthase; Endothelium derived hyperpolarizing factor; Microveesels; Nitric oxide

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE; CAVEOLIN 1; CYCLIC GMP DEPENDENT PROTEIN KINASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; NITRIC OXIDE;

ANIMAL TISSUE; AORTA; ARTICLE; CONTROLLED STUDY; ELECTROPHYSIOLOGY; ENZYME PHOSPHORYLATION; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MALE; MESENTERIC ARTERY; MICROVASCULATURE; MOUSE; NONHUMAN; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

ANIMALS; BIOLOGICAL FACTORS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE KINASE; CAVEOLIN 1; CYCLIC GMP-DEPENDENT PROTEIN KINASES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; MALE; MESENTERY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROVESSELS; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; SIGNAL TRANSDUCTION; VASODILATION; VASODILATOR AGENTS;

EID: 84863215782     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-12-0197     Document Type: Article

References (41)

1. Feletou M, Vanhoutte PM. Endothelium-derived hyperpolarizing factor: Where are we now? Arterioscler Thromb Vasc Biol 2006; 26: 1215-1225.
2. Shimokawa H. Primary endothelial dysfunction: Atherosclerosis. J Mol Cell Cardiol 1999; 31: 23-37.
3. Busse R, Edwards G, Feletou M, Fleming I, Vanhoutte PM, Weston AH. EDHF: Bringing the concepts together. Trends Pharmacol Sci 2002; 23: 374-380.
4. Shimokawa H, Morikawa K. Hydrogen peroxide is an endotheliumderived hyperpolarizing factor in animals and humans. J Mol Cell Cardiol 2005; 39: 725-732.
5. Shimokawa H. Hydrogen peroxide as an endothelium-derived hyperpolarizing factor. Pflugers Arch 2010; 459: 915-922.
6. Vanhoutte PM. Endothelial dysfunction: The first step toward coronary arteriosclerosis. Circ J 2009; 73: 595-601.
7. Shimokawa H, Yasutake H, Fujii K, Owada MK, Nakaike R, Fukumoto Y, et al. The importance of the hyperpolarizing mechanism increases as the vessel size decreases in endothelium-dependent relaxations in rat mesenteric circulation. J Cardiovasc Pharmacol 1996; 28: 703-711.
8. Urakami-Harasawa L, Shimokawa H, Nakashima M, Egashira K, Takeshita A. Importance of endothelium-derived hyperpolarizing factor in human arteries. J Clin Invest 1997; 100: 2793-2799.
9. 2 and epoxyeicosatrienoic acids in relaxation of bovine coronary arteries to arachidonic acid. Am J Physiol 1993; 264: H327-H335.
10. Fisslthaler B, Popp R, Kiss L, Potente M, Harder DR, Fleming I, et al. Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature 1999; 401: 493-497.
11. + is an endothelium-derived hyperpolarizing factor in rat arteries. Nature 1998; 396: 269-272.
12. Beny JL, Schaad O. An evaluation of potassium ions as endotheliumderived hyperpolarizing factor in porcine coronary arteries. Br J Pharmacol 2000; 131: 965-973.
13. Taylor HJ, Chaytor AT, Evans WH, Griffith TM. Inhibition of the gap junctional component of endothelium-dependent relaxations in rabbit iliac artery by 18-α glycyrrhetinic acid. Br J Pharmacol 1998; 125: 1-3.
14. Yamamoto Y, Fukuta H, Nakahira Y, Suzuki H. Blockade by 18β-glycyrrhetinic acid of intercellular electrical coupling in guinea-pig arterioles. J Physiol 1998; 511 (Pt 2): 501-508.
15. Matoba T, Shimokawa H, Nakashima M, Hirakawa Y, Mukai Y, Hirano K, et al. Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice. J Clin Invest 2000; 106: 1521-1530.
16. Matoba T, Shimokawa H, Kubota H, Morikawa K, Fujiki T, Kunihiro I, et al. Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in human mesenteric arteries. Biochem Biophys Res Commun 2002; 290: 909-913.
17. Matoba T, Shimokawa H, Morikawa K, Kubota H, Kunihiro I, Urakami-Harasawa L, et al. Electron spin resonance detection of hydrogen peroxide as an endothelium-derived hyperpolarizing factor in porcine coronary microvessels. Arterioscler Thromb Vasc Biol 2003; 23: 1224-1230.
18. Miura H, Bosnjak JJ, Ning G, Saito T, Miura M, Gutterman DD. Role for hydrogen peroxide in flow-induced dilation of human coronary arterioles. Circ Res 2003; 92: e31-e40.
19. Yada T, Shimokawa H, Hiramatsu O, Kajita T, Shigeto F, Goto M, et al. Hydrogen peroxide, an endogenous endothelium-derived hyperpolarizing factor, plays an important role in coronary autoregulation in vivo. Circulation 2003; 107: 1040-1045.
20. Yada T, Shimokawa H, Hiramatsu O, Haruna Y, Morita Y, Kashihara N, et al. Cardioprotective role of endogenous hydrogen peroxide during ischemia-reperfusion injury in canine coronary microcirculation in vivo. Am J Physiol 2006; 291: H1138-H1146.
21. Lacza Z, Puskar M, Kis B, Perciaccante JV, Miller AW, Busija DW. Hydrogen peroxide acts as an EDHF in the piglet pial vasculature in response to bradykinin. Am J Physiol 2002; 283: H406-H411.
22. Takaki A, Morikawa K, Tsutsui M, Murayama Y, Tekes E, Yamagishi H, et al. Crucial role of nitric oxide synthases system in endotheliumdependent hyperpolarization in mice. J Exp Med 2008; 205: 2053-2063.
23. Takaki A, Morikawa K, Murayama Y, Yamagishi H, Hosoya M, Ohashi J, et al. Roles of endothelial oxidases in endothelium-derived hyperpolarizing factor responses in mice. J Cardiovasc Pharmacol 2008; 52: 510-517.
24. Morikawa K, Shimokawa H, Matoba T, Kubota H, Akaike T, Talukder MA, et al. Pivotal role of Cu, Zn-superoxide dismutase in endothelium-dependent hyperpolarization. J Clin Invest 2003; 112: 1871-1879.
25. Morikawa K, Fujiki T, Matoba T, Kubota H, Hatanaka M, Takahashi S, et al. Important role of superoxide dismutase in EDHF-mediated responses of human mesenteric arteries. J Cardiovasc Pharmacol 2004; 44: 552-556.
26. Yada T, Shimokawa H, Hiramatsu O, Shinozaki Y, Mori H, Goto M, et al. Important role of endogenous hydrogen peroxide in pacinginduced metabolic coronary vasodilation in dogs in vivo. J Am Coll Cardiol 2007; 50: 1272-1278.
27. Levine YC, Li GK, Michel T. Agonist-modulated regulation of AMPactivated protein kinase (AMPK) in endothelial cells: Evidence for an AMPK → Rac1 → Akt → endothelial nitric-oxide synthase pathway. J Biol Chem 2007; 282: 20351-20364.
28. Li X, Han Y, Pang W, Li C, Xie X, Shyy JY, et al. AMP-activated protein kinase promotes the differentiation of endothelial progenitor cells. Arterioscler Thromb Vasc Biol 2008; 28: 1789-1795.
29. Potenza MA, Marasciulo FL, Chieppa DM, Brigiani GS, Formoso G, Quon MJ, et al. Insulin resistance in spontaneously hypertensive rats is associated with endothelial dysfunction characterized by imbalance between NO and ET-1 production. Am J Physiol 2005; 289: H813-H822.
30. Burgoyne JR, Madhani M, Cuello F, Charles RL, Brennan JP, Schroder E, et al. Cysteine redox sensor in PKG1α enables oxidant-induced activation. Science 2007; 317: 1393-1397.
31. Hosoya M, Ohashi J, Sawada A, Takaki A, Shimokawa H. Combination therapy with olmesartan and azelnidipine improves EDHF-mediated responses in diabetic apolipoprotein E-deficient mice. Circ J 2010; 74: 798-806.
32. Gao JY, Yasuda S, Tsuburaya R, Ito Y, Shiroto T, Hao K, et al. Long-term treatment with eicosapentaenoic acid ameliorates myocardial ischemia-reperfusion injury in pigs in vivo: Involvement of Rho-kinase pathway inhibition. Circ J 2011; 75: 1843-1851.
33. Fleming I. Molecular mechanisms underlying the activation of eNOS. Pflugers Arch 2010; 459: 793-806.
34. 2+/calmodulin-dependent protein kinase kinase. J Biol Chem 2002; 277: 15813-15818.
35. Prysyazhna O, Rudyk O, Eaton P. Single atom substitution in mouse protein kinase G eliminates oxidant sensing to cause hypertension. Nat Med 2012; 18: 286-290.
36. Hsu HH, Duning K, Meyer HH, Stolting M, Weide T, Kreusser S, et al. Hypertension in mice lacking the CXCR3 chemokine receptor. Am J Physiol 2009; 296: R780-R789.
37. 2+ store in fresh endothelial cells and evidence for ryanodine receptors. Circ Res 1995; 77: 37-42.
38. 2+ signals and gap junction function are regulated by caveolin in endothelial cells. Circulation 2008; 117: 1065-1074.
39. Pojoga LH, Yao TM, Sinha S, Ross RL, Lin JC, Raffetto JD, et al. Effect of dietary sodium on vasoconstriction and eNOS-mediated vascular relaxation in caveolin-1-deficient mice. Am J Physiol 2008; 294: H1258-H1265.
40. Stuehr D, Pou S, Rosen GM. Oxygen reduction by nitric-oxide synthases. J Biol Chem 2001; 276: 14533-14536.
41. Ghosh S, Gachhui R, Crooks C, Wu C, Lisanti MP, Stuehr DJ. Interaction between caveolin-1 and the reductase domain of endothelial nitric-oxide synthase: Consequences for catalysis. J Biol Chem 1998; 273: 22267-22271.